Immunomodulating Nanomedicine for Cancer Therapy

被引：128

作者：

Liu, Zhigang ^{[1
,2
]}

Jiang, Wen ^{[2
]}

Nam, Jutaek ^{[3
,4
]}

Moon, James J. ^{[3
,4
,5
]}

Kim, Betty Y. S. ^{[6
,7
,8
]}

机构：

[1] Cent South Univ, Hunan Canc Hosp, Key Lab Translat Radiat Oncol, Dept Radiotherapy,Affiliated Canc Hosp,Xiangya Sc, Changsha 410013, Hunan, Peoples R China

[2] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA

[3] Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA

[4] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA

[5] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA

[6] Mayo Clin, Dept Neurosurg, Jacksonville, FL 32224 USA

[7] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA

[8] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA

来源：

NANO LETTERS | 2018年 / 18卷 / 11期

基金：

中国国家自然科学基金;

关键词：

Nanomedicine; cancer immunotherapy; cancer vaccine; drug delivery; nanotechnology; ANTIGEN-PRESENTING CELLS; RNA DELIVERY; T-CELLS; NANOPARTICLES; EXPANSION; AGONISTS; DESIGN; DEATH;

D O I：

10.1021/acs.nanolett.8b02340

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Nanomaterials offer unique advantages as drug-delivery vehicles for cancer therapeutics. For immuno-oncology applications, cancer nanomedicine should be developed beyond drug-delivery platforms. A greater emphasis on actively modulating host anticancer immunity using nanomaterials provides new avenues for developing novel cancer therapeutics.

引用

页码：6655 / 6659

页数：5

共 38 条

[31] Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors [J].

Smith, Tyrel T. ;

Moffett, Howell F. ;

Stephan, Sirkka B. ;

Opel, Cary F. ;

Dumigan, Amy G. ;

Jiang, Xiuyun ;

Pillarisetty, Venu G. ;

Pillai, Smitha P. S. ;

Wittrup, K. Dane ;

Stephan, Matthias T. .

JOURNAL OF CLINICAL INVESTIGATION, 2017, 127 (06) :2176-2191

[32] Tumor Microenvironment Responsive Nanogel for the Combinatorial Antitumor Effect of Chemotherapy and Immunotherapy [J].

Song, Qingle ;

Yin, Yijia ;

Shang, Lihuan ;

Wu, Tingting ;

Zhang, Dan ;

Kong, Miao ;

Zhao, Yongdan ;

He, Yangzhou ;

Tan, Songwei ;

Guo, Yuanyuan ;

Zhang, Zhiping .

NANO LETTERS, 2017, 17 (10) :6366-6375

[33] In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy [J].

Wang, Chao ;

Sun, Wujin ;

Ye, Yanqi ;

Hu, Quanyin ;

Bomba, Hunter N. ;

Gu, Zhen .

NATURE BIOMEDICAL ENGINEERING, 2017, 1 (02)

[34] Analysis of nanoparticle delivery to tumours [J].

Wilhelm, Stefan ;

Tavares, Anthony J. ;

Dai, Qin ;

Ohta, Seiichi ;

Audet, Julie ;

Dvorak, Harold F. ;

Chan, Warren C. W. .

NATURE REVIEWS MATERIALS, 2016, 1 (05)

[35]

Xue JW, 2017, NAT NANOTECHNOL, V12, P692, DOI [10.1038/nnano.2017.54, 10.1038/NNANO.2017.54]

[36]

Yuan HF, 2017, NAT NANOTECHNOL, V12, P763, DOI [10.1038/nnano.2017.69, 10.1038/NNANO.2017.69]

[37]

Zanganeh S, 2016, NAT NANOTECHNOL, V11, P986, DOI [10.1038/nnano.2016.168, 10.1038/NNANO.2016.168]

[38]

Zhang C, 2017, NAT NANOTECHNOL, V12, P378, DOI [10.1038/NNANO.2016.280, 10.1038/nnano.2016.280]

← 1 2 3 4 →